Genomictree Inc. (228760.KQ) — Stock Score Summary

Genomictree Inc. (228760.KQ) has a MoatMap StockRank of 15/100 based on Quality (41/100), Value (40/100), and Momentum (18/100) factor scores. The current signal is STRONG SELL. Genomictree is a South Korean molecular diagnostics company. Despite operating in healthcare, it lacks the pricing power, high ROIC, and structural tailwinds of our core themes, showing poor quality metrics that fail our Terry Smith filter.

Genomictree Inc. is a molecular diagnostics company specializing in the early detection of cancer using proprietary DNA methylation biomarkers. The company's competitive advantage is anchored in its non-invasive, highly sensitive EarlyTect diagnostic kits, notably for colorectal cancer screening. It operates as a pioneering biotechnology player in the liquid biopsy and early cancer detection market.

Key Financial Metrics

Price$8.03
Market Cap$216M
Price/Book2.34
Return on Invested Capital-7.5%
Debt/Equity0.04
Gross Margin-114.5%
Operating Margin-793.9%
Revenue Growth20.6%

Genomictree Inc. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Genomictree Inc.’s (228760.KQ) StockRank?
MoatMap’s StockRank for Genomictree Inc. (228760.KQ) is 15/100, with a Strong Sell signal. It is a composite of Quality (41), Value (40), and Momentum (18) factor ranks across MoatMap’s 19,000+ stock universe.
Does Genomictree Inc. have an economic moat?
Genomictree Inc. (228760.KQ) has a Quality factor score of 41/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Genomictree Inc. a buy, hold, or sell?
MoatMap’s current signal for Genomictree Inc. (228760.KQ) is Strong Sell, based on a StockRank of 15/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Genomictree Inc. in?
Genomictree Inc. (228760.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks228760.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock